Trials / Not Yet Recruiting
Not Yet RecruitingNCT06520592
The Effectiveness of Augmented Reality to Enhance CPAP Therapy in OSA Patients
Using Augmented Reality to Establish and Evaluate the Effectiveness of a Set of Continuous Positive Airway Pressure Care Management Protocol for Obstructive Sleep Apnea Patients
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- National Cheng-Kung University Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to exam if artificial reality works to improve continuous positive airway pressure (CPAP) adherence in obstructive sleep apnea (OSA) patients. It will also learn about the feasibility of AR guided CPAP therapy. The main questions it aims to answer are: Does AR guided CPAP therapy increase the adherence of CPAP therapy among OSA patients? What barriers do participants have when using AR guided CPAP therapy? Researchers will compare AR guided CPAP therapy to a control (standard of care) to see if AR guided CPAP therapy works to enhance the adherence of CPAP therapy. Participants will: 1. Take AR guided CPAP therapy or standard of care every day for 6 months 2. Visit the clinic on baseline (t0), receiving CPAP therapy at the 1st month (t1), for checkups and tests, receiving CPAP therapy at the 3rd month (t2), receiving CPAP therapy at the 6th month (t3). 3. Response their symptoms on each following time.
Detailed description
Participants will randomly assign to two group, for experimental group will be received AR guided CPAP therapy. In the control group will be received standard of care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | With AR guided CPAP therapy | Participants will received AR training course to utilize the AR guided CPAP therapy |
Timeline
- Start date
- 2025-06-20
- Primary completion
- 2025-12-31
- Completion
- 2026-07-31
- First posted
- 2024-07-25
- Last updated
- 2025-05-21
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06520592. Inclusion in this directory is not an endorsement.